Hubei Biocause Pharmaceutical (000627) — Cash Flow-to-Debt Ratio
Hubei Biocause Pharmaceutical (000627) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2023, meaning its operating cash flow of CN¥276.06 Million could theoretically repay 0% of its total liabilities (CN¥272.50 Billion) in one year. See Hubei Biocause Pharmaceutical financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hubei Biocause Pharmaceutical Cash Flow-to-Debt Ratio (2001–2023)
Historical debt coverage capacity for Hubei Biocause Pharmaceutical across 18 annual periods. For the full cash flow conversion analysis, see Hubei Biocause Pharmaceutical operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Hubei Biocause Pharmaceutical (2001–2023)
Year-by-year debt coverage analysis for Hubei Biocause Pharmaceutical. Check 000627 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | CN¥9.53 Billion | CN¥268.30 Billion | ▲ +20.0% |
| 2022 | 0.03x | CN¥7.52 Billion | CN¥254.00 Billion | ▲ +60.8% |
| 2021 | 0.02x | CN¥4.17 Billion | CN¥226.43 Billion | ▼ -82.4% |
| 2020 | 0.10x | CN¥21.42 Billion | CN¥204.81 Billion | ▼ -37.5% |
| 2019 | 0.17x | CN¥28.60 Billion | CN¥170.92 Billion | ▲ +70.0% |
| 2018 | 0.10x | CN¥14.98 Billion | CN¥152.24 Billion | ▲ +2492.8% |
| 2017 | 0.00x | CN¥431.58 Million | CN¥113.71 Billion | ▲ +115.8% |
| 2016 | -0.02x | CN¥-2.34 Billion | CN¥97.48 Billion | ▲ +67.8% |
| 2015 | -0.07x | CN¥-46.73 Million | CN¥625.50 Million | ▼ -141.3% |
| 2013 | 0.18x | CN¥130.53 Million | CN¥720.71 Million | ▲ +1.8% |
| 2012 | 0.18x | CN¥93.79 Million | CN¥527.37 Million | ▲ +24.7% |
| 2011 | 0.14x | CN¥66.95 Million | CN¥469.47 Million | ▼ -76.2% |
| 2010 | 0.60x | CN¥224.58 Million | CN¥374.25 Million | ▲ +132.1% |
| 2007 | 0.26x | CN¥118.56 Million | CN¥458.52 Million | ▼ -10.5% |
| 2006 | 0.29x | CN¥128.19 Million | CN¥443.66 Million | ▲ +111.8% |
| 2005 | 0.14x | CN¥48.66 Million | CN¥356.70 Million | ▼ -13.0% |
| 2004 | 0.16x | CN¥56.07 Million | CN¥357.41 Million | ▼ -4.9% |
| 2001 | 0.16x | CN¥37.30 Million | CN¥226.09 Million | — |